• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

换血疗法作为重症恶性疟治疗的辅助手段。

Exchange transfusion as an adjunct to the treatment of severe falciparum malaria.

作者信息

Hoontrakoon S, Suputtamongkol Y

机构信息

Department of Medicine, Chumphorn Hospital, Thailand.

出版信息

Trop Med Int Health. 1998 Feb;3(2):156-61. doi: 10.1111/j.1365-3156.1998.00198.x.

DOI:10.1111/j.1365-3156.1998.00198.x
PMID:9537279
Abstract

OBJECTIVE

To compare the efficacy of exchange transfusion as the adjunct to quinine treatment (21 patients) with quinine therapy alone (29 patients).

METHOD

A retrospective study of 50 patients with severe falciparum malaria was conducted at Chumphorn Hospital, Southern Thailand.

RESULTS

Clinical characteristics in both treatment groups were not significantly different although in the exchange transfusion group, the admission geometric mean parasitaemia (18 (5%), and the proportion of patients with more than 10% parasitaemia was higher (76%, P = 0.03) than in the group who received quinine alone (10 +/- 4%; 38%, P = 0.1). The mortality rate of patients who received exchange transfusion was 48%; that of the remainder, 69%. (P = 0.3). ARDS (P = 0.01) and oliguric renal failure (P = 0.04) were significant risk factors for death in these patients.

CONCLUSION

Exchange transfusion was safe and well tolerated. Results of our study revealed a 20% reduction in mortality when exchange transfusion was used as an adjunct to quinine treatment. It should therefore be considered in patients with severe falciparum malaria when possible.

摘要

目的

比较换血疗法作为奎宁治疗辅助手段(21例患者)与单纯奎宁治疗(29例患者)的疗效。

方法

对泰国南部春蓬医院50例重症恶性疟患者进行回顾性研究。

结果

尽管换血治疗组入院时疟原虫血症几何均数(18(5%))以及疟原虫血症超过10%的患者比例(76%,P = 0.03)高于单纯接受奎宁治疗的组(10 +/- 4%;38%,P = 0.1),但两个治疗组的临床特征无显著差异。接受换血治疗患者的死亡率为48%;其余患者的死亡率为69%。(P = 0.3)。急性呼吸窘迫综合征(P = 0.01)和少尿性肾衰竭(P = 0.04)是这些患者死亡的显著危险因素。

结论

换血疗法安全且耐受性良好。我们的研究结果显示,换血疗法作为奎宁治疗的辅助手段时,死亡率降低了20%。因此,对于重症恶性疟患者,应尽可能考虑采用该疗法。

相似文献

1
Exchange transfusion as an adjunct to the treatment of severe falciparum malaria.换血疗法作为重症恶性疟治疗的辅助手段。
Trop Med Int Health. 1998 Feb;3(2):156-61. doi: 10.1111/j.1365-3156.1998.00198.x.
2
Exchange transfusion in children with severe falciparum malaria and heavy parasitaemia.重症恶性疟原虫疟疾和高寄生虫血症患儿的换血疗法。
Ann Trop Paediatr. 2006 Sep;26(3):199-204. doi: 10.1179/146532806X120282.
3
Manual blood exchange transfusion does not significantly contribute to parasite clearance in artesunate-treated individuals with imported severe Plasmodium falciparum malaria.在青蒿琥酯治疗的输入性严重恶性疟患者中,手工换血输血对寄生虫清除并无明显作用。
Malar J. 2013 Mar 27;12:115. doi: 10.1186/1475-2875-12-115.
4
Exchange transfusion in severe falciparum malaria.重症恶性疟的换血疗法。
J Med Assoc Thai. 1999 Jan;82(1):1-8.
5
Partial exchange transfusion in the treatment of severe falciparum malaria.部分换血疗法治疗重症恶性疟
Natl Med J India. 1996 Jul-Aug;9(4):163-5.
6
Efficacy and safety of exchange transfusion as an adjunct therapy for severe Plasmodium falciparum malaria in nonimmune travelers: a 10-year single-center experience with a standardized treatment protocol.换血疗法作为非免疫旅行者重症恶性疟辅助治疗的疗效和安全性:采用标准化治疗方案的 10 年单中心经验
Transfusion. 2010 Apr;50(4):787-94. doi: 10.1111/j.1537-2995.2009.02488.x. Epub 2009 Nov 20.
7
[Exchange blood transfusion and P. falciparum malaria].
Med Clin (Barc). 2000 Jan 15;114(1):37-8. doi: 10.1016/s0025-7753(00)71180-8.
8
A case of imported severe plasmodium falciparum malaria in the emergency department and the current role of exchange transfusion treatment.急诊科1例输入性重症恶性疟病例及换血治疗的当前作用
J Emerg Med. 2013 Feb;44(2):e211-5. doi: 10.1016/j.jemermed.2012.02.051. Epub 2012 May 18.
9
Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis.换血疗法作为重症恶性疟原虫疟疾的辅助治疗:一项荟萃分析。
Clin Infect Dis. 2002 May 1;34(9):1192-8. doi: 10.1086/339810. Epub 2002 Apr 3.
10
Exchange transfusion therapy in severe complicated malaria.重症复杂疟疾的换血疗法
J Med Assoc Thai. 1997 May;80(5):332-7.

引用本文的文献

1
Exchange transfusion combined with artesunate (ET-AS) as a safe and effective therapy in severe P. falciparum malaria: a case series.青蒿琥酯联合换血疗法治疗重症恶性疟:病例系列。
BMC Infect Dis. 2024 Jun 19;24(1):603. doi: 10.1186/s12879-024-09381-2.
2
Management of Hyperparasitaemia in Severe Malaria: A Sea Change With the Availability of Artesunate.重症疟疾中高寄生虫血症的管理:青蒿琥酯的可及性带来的巨大变化
Cureus. 2024 Mar 25;16(3):e56894. doi: 10.7759/cureus.56894. eCollection 2024 Mar.
3
Exchange transfusion in complicated pediatric malaria: A critical appraisal.
复杂小儿疟疾中的换血疗法:一项批判性评估。
Indian J Crit Care Med. 2015 Apr;19(4):214-9. doi: 10.4103/0972-5229.154554.
4
Severe sepsis due to severe falciparum malaria and leptospirosis co-infection treated with activated protein C.因严重恶性疟原虫疟疾和钩端螺旋体病合并感染导致的严重脓毒症,采用活化蛋白C进行治疗。
Malar J. 2007 Apr 12;6:42. doi: 10.1186/1475-2875-6-42.